Target intelligence / Profile preview

Risky substance avoidance

01

Overview

"Risky substance avoidance" refers to an individual's tendency or capacity to refrain from using potentially addictive substances. This concept represents a **protective factor**, reducing the likelihood that someone will develop substance use disorder (SUD)[4][5]. The propensity for risky substance avoidance arises from complex interactions between biological factors (such as genetics and neurobiology), psychological traits (like self-control), environmental influences, and life experiences[2][3]. While certain brain regions—most notably the prefrontal cortex—are implicated in decision-making processes that underlie this behavior, there is no single molecule or receptor responsible for "risky substance avoidance"[1]. Instead, it reflects an emergent property of multiple neural circuits involved in executive function and impulse control. As such, it cannot be classified as a therapeutic target like receptors or enzymes can be. In summary: - **Not a molecular target**, but rather describes protective behaviors/factors influencing addiction risk. - **No abbreviation**, aliases are descriptive only. - **Not suitable for structured data fields intended for molecules/receptors/genes. If you need information on specific molecules/receptors involved in these behaviors—such as dopamine receptors, serotonin transporters, CRF receptors—or want details about targets relevant to addiction biology more broadly, please specify further.

Other names
Substance use risk avoidanceAvoidance of addictive substancesProtective behavior against drug use
02

Biological functions

Behavioral inhibition (as it relates to avoiding risky substances)Decision-making and impulse control (mediated by brain regions such as the prefrontal cortex)
03

Disease associations

Other: Risk/protective factor for substance use disorder/addictionNot itself causative but influences likelihood of developing SUD

Beyond the preview

Go deeper on Risky substance avoidance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Risky substance avoidance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call